Treatment of acute rejection with anti-T-cell antigen receptor complex αβ (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: Results of a prospective randomized double-blind trial
- T. H. Waid
- , B. A. Lucas
- , J. S. Thompson
- , L. C. Munch
- , S. Brown
- , R. Kryscio
- , R. Prebeck
- , M. A. VanHoy
- , D. Jezek
Producción científica: Article › revisión exhaustiva
21
Citas
(Scopus)